98%
921
2 minutes
20
The Cardiometabolic Index (CMI) is a new indicator of visceral fat distribution and dysfunction that can be calculated using lipid parameters, waist circumference, and height. The relationship between CMI and Obstructive Sleep Apnea (OSA) remains unclear. This cross-sectional study explored the association between CMI and OSA using nationally representative data from The National Health and Nutrition Examination Survey database, spanning the periods from 2005 to 2008 and 2015 to 2018. OSA was self-reported based on questionnaire responses. Weighted logistic regression and restricted cubic splines were used to investigate the relationship between CMI and OSA. In addition, subgroup analyses and interaction tests were performed to study the robustness of the association across different populations. Finally, a receiver operating characteristic curve (ROC) was used to determine the predictive power of the index for the OSA. A total of 8460 participants were enrolled in the study. In the fully adjusted model, multivariate regression revealed a significant relationship between CMI and OSA (OR = 1.75, 95% CI 1.46-2.10). Interaction tests, revealed no significant effects of age, sex, body mass index, and race on the relationship between CMI and OSA. The area under the curve (AUC) of the ROC curve was 0.605, indicating that CMI has a predictive value for the OSA. This study provides evidence that CMI is associated with OSA in the adult population of the United States. CMI may be an important predictor of OSA, which provides a new perspective for the future assessment and treatment of individuals with odds of OSA.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12325783 | PMC |
http://dx.doi.org/10.1038/s41598-025-03186-2 | DOI Listing |
Semin Vasc Surg
September 2025
Division of Vascular and Endovascular Surgery, Department of Surgery, Stony Brook University Hospital, Health Sciences Tower, Stony Brook, NY, 11794. Electronic address:
Chronic mesenteric ischemia (CMI) is a rare, yet increasingly prevalent, condition, especially among older adults. Diagnosing CMI in older adults presents significant challenges. Along with the burden of comorbidities and the physiological changes associated with aging, timely intervention is often delayed, leading to poorer outcomes.
View Article and Find Full Text PDFClin Microbiol Infect
September 2025
Department of Intensive Care Unit, Tiantai People's Hospital of Zhejiang Province (Tiantai Branch of Zhejiang Provincial People's Hospital), Hangzhou Medical College,Tiantai, Taizhou, Zhejiang, 317200,China. Electronic address:
Hernia
September 2025
Unit of Abdominal wall surgery, Department of Digestive Surgery, Hospital Universitari i Poltecnic La Fe, Calle Gabriel Miró 28, puerta 12, Valencia, 46008, Spain.
Background: This study aimed to analyze the outcomes of patients undergoing ventral hernia repair (VHR) with a polypropylene mesh with embedded silver ions (PSM) in the context of different degrees of contamination, compared to standard conventional macroporous polypropylene mesh (PPL).
Methods: From May 2019 to October 2023, a retrospective comparative analysis of patients who underwent elective or urgent VHR with a SilverMesh (PSM group) versus standard macroporous polypropylene mesh (PPL group), based on the Spanish Hernia registry (EVEREG). The exclusion criteria were other PSM indications (groin hernia, prophylaxis) and the use of composite meshes or any material different to PPL.
Clin Neurophysiol
August 2025
Clinical Neurophysiology Department, AP-HP, Hôpital Necker Enfants Malades, Paris, France; Paris Cité University, Paris, France; Centre de référence des pathologies neuromusculaires Paris-Nord-Est, AP-HP, Hôpital Necker Enfants Malades, Paris, France.
Objective: Higher compound muscle action potentials (CMAP) amplitudes are associated with motor milestones acquisitions in patients with symptomatic early onset spinal muscular atrophy (SMA) after gene therapy (GT). This study aimed to propose a predictive model for the evolution of CMAP amplitudes over 36 months in these patients.
Methods: Nineteen SMA patients (mean age 8.
J Clin Transl Endocrinol
September 2025
School of Nursing, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310051, China.
Background: The cardiometabolic index (CMI) is a reliable marker used to assess the degree of obesity and lipid metabolism disorders in individuals. Emerging evidence indicates that disorders of lipid metabolism and sarcopenia share a common pathophysiologic basis. However, few studies have investigated the association between CMI and sarcopenia.
View Article and Find Full Text PDF